Tango Therapeutics (TNGX) EBITDA Margin Growth (1y) (2021 - 2025)
Tango Therapeutics (TNGX) EBITDA Margin Growth (1y) (2021 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Tango Therapeutics |
4.05 Bn |
3.67 Bn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
30,941.00 |
| Jun 30, 2025 |
-113,918.00 |
| Mar 31, 2025 |
-19,601.00 |
| Dec 31, 2024 |
-44,322.00 |
| Sep 30, 2024 |
-8,360.00 |
| Jun 30, 2024 |
-1,151.00 |
| Mar 31, 2024 |
-13,309.00 |
| Dec 31, 2023 |
-11,514.00 |
| Sep 30, 2023 |
22,750.00 |
| Jun 30, 2023 |
30,979.00 |
| Mar 31, 2023 |
2,407.00 |
| Dec 31, 2022 |
-3,643.00 |
| Sep 30, 2022 |
-13,834.00 |
| Jun 30, 2022 |
-42,206.00 |
| Mar 31, 2022 |
-29,439.00 |
| Dec 31, 2021 |
-25,509.00 |
| Sep 30, 2021 |
-5,094.00 |
